PPM1D exerts negative regulation on several tumor suppressor pathways, including ATM, CHK2, p38 MAPK, and p53, contributing to enhanced osteosarcoma proliferation and migration through the upregulation of PKP2, which has potential as an early diagnostic biomarker for the disease (19). Here, PKP2 is linked to osteosarcoma.